Stifel Financial
RDY icon

Stifel Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Stifel Financial’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Buy
27,004
+1,135
+4% +$15.3K ﹤0.01% 3129
2026
Q1 		$358K Buy
25,869
+2,405
+10% +$33.5K ﹤0.01% 3067
2025
Q4 		$329K Buy
23,464
+861
+4% +$12.1K ﹤0.01% 3095
2025
Q3 		$316K Buy
22,603
+1,336
+6% +$19.2K ﹤0.01% 3078
2025
Q2 		$320K Sell
21,267
-10,964
-34% -$157K ﹤0.01% 3017
2025
Q1 		$425K Sell
32,231
-886
-3% -$12.2K ﹤0.01% 2796
2024
Q4 		$523K Buy
33,117
+9,187
+38% +$138K ﹤0.01% 2648
2024
Q3 		$380K Sell
23,930
-1,730
-7% -$27.8K ﹤0.01% 2831
2024
Q2 		$391K Sell
25,660
-815
-3% -$11.7K ﹤0.01% 2778
2024
Q1 		$388K Buy
26,475
+40
+0.2% +$584 ﹤0.01% 2749
2023
Q4 		$368K Sell
26,435
-185
-0.7% -$2.47K ﹤0.01% 2730
2023
Q3 		$356K Buy
26,620
+120
+0.5% +$1.62K ﹤0.01% 2688
2023
Q2 		$334K Sell
26,500
-1,110
-4% -$13K ﹤0.01% 2753
2023
Q1 		$314K Buy
27,610
+1,865
+7% +$20.1K ﹤0.01% 2783
2022
Q4 		$266K Sell
25,745
-980
-4% -$10.6K ﹤0.01% 2836
2022
Q3 		$280K Sell
26,725
-240
-0.9% -$2.56K ﹤0.01% 2757
2022
Q2 		$299K Buy
26,965
+1,490
+6% +$16.2K ﹤0.01% 2755
2022
Q1 		$284K Buy
25,475
+135
+0.5% +$1.53K ﹤0.01% 2902
2021
Q4 		$332K Sell
25,340
-560
-2% -$7.06K ﹤0.01% 2853
2021
Q3 		$337K Sell
25,900
-1,995
-7% -$26.6K ﹤0.01% 2830
2021
Q2 		$410K Buy
27,895
+2,945
+12% +$41.2K ﹤0.01% 2700
2021
Q1 		$306K Sell
24,950
-99,320
-80% -$1.28M ﹤0.01% 2778
2020
Q4 		$1.77M Buy
124,270
+4,000
+3% +$53.9K ﹤0.01% 1459
2020
Q3 		$1.67M Sell
120,270
-1,030
-0.8% -$12.3K ﹤0.01% 1317
2020
Q2 		$1.29M Buy
121,300
+8,515
+8% +$86.6K ﹤0.01% 1398
2020
Q1 		$924K Sell
112,785
-11,545
-9% -$96.3K ﹤0.01% 1483
2019
Q4 		$1.03M Sell
124,330
-2,205
-2% -$17.4K ﹤0.01% 1812
2019
Q3 		$969K Sell
126,535
-1,055
-0.8% -$7.85K ﹤0.01% 1774
2019
Q2 		$964K Buy
+127,590
New +$1M ﹤0.01% 1826

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Stifel Financial's RDY Position: Q2 2026 in Review

Stifel Financial increased its Dr. Reddy's Laboratories (RDY) stake by 4.4% in Q2 2026, buying an estimated $15.3K and bringing the position to 27,004 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Stifel Financial first reported a position in RDY in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.77M in Q4 2020. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Stifel Financial held 27,004 shares of Dr. Reddy's Laboratories worth $391K as of Q2 2026.
  • Stifel Financial bought 1,135 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $15.3K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3129 holding.
  • Stifel Financial first reported a position in Dr. Reddy's Laboratories in Q2 2019 and has held it in 29 quarters since.
  • Stifel Financial's Dr. Reddy's Laboratories position peaked at $1.77M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.